Biochemical modulation of fluoropyrimidines: Is there an optimal (6R,S)leucovorin dose and schedule?

被引:7
作者
Doroshow, JH
机构
关键词
D O I
10.1093/jnci/88.7.393
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:393 / 395
页数:3
相关论文
共 24 条
[1]  
BOARMAN DM, 1992, CANCER RES, V52, P36
[2]   RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER [J].
BUROKER, TR ;
OCONNELL, MJ ;
WIEAND, HS ;
KROOK, JE ;
GERSTNER, JB ;
MAILLIARD, JA ;
SCHAEFER, PL ;
LEVITT, R ;
KARDINAL, CG ;
GESME, DH .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :14-20
[3]   Role of fluoropyrimidine schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma [J].
Cao, SS ;
Frank, C ;
Rustum, YM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (07) :430-436
[4]  
CREAVEN PJ, 1994, CANCER CHEMOTH PHARM, V34, P261
[5]   EFFECT OF 5,10-METHYLENETETRAHYDROFOLATE ON DISSOCIATION OF 5-FLUORO-2'-DEOXYURIDYLATE FROM THYMIDYLATE SYNTHETASE - EVIDENCE FOR AN ORDERED MECHANISM [J].
DANENBERG, PV ;
DANENBERG, KD .
BIOCHEMISTRY, 1978, 17 (19) :4018-4024
[6]   PROSPECTIVE RANDOMIZED COMPARISON OF FLUOROURACIL VERSUS FLUOROURACIL AND HIGH-DOSE CONTINUOUS INFUSION LEUCOVORIN CALCIUM FOR THE TREATMENT OF ADVANCED MEASURABLE COLORECTAL-CANCER IN PATIENTS PREVIOUSLY UNEXPOSED TO CHEMOTHERAPY [J].
DOROSHOW, JH ;
MULTHAUF, P ;
LEONG, L ;
MARGOLIN, K ;
LITCHFIELD, T ;
AKMAN, S ;
CARR, B ;
BERTRAND, M ;
GOLDBERG, D ;
BLAYNEY, D ;
ODUJINRIN, O ;
DELAP, R ;
SHUSTER, J ;
NEWMAN, E .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :491-501
[7]   THE EFFECT OF DOSE AND INTERVAL BETWEEN 5-FLUOROURACIL AND LEUCOVORIN ON THE FORMATION OF THYMIDYLATE SYNTHASE TERNARY COMPLEX IN HUMAN CANCER-CELLS [J].
DRAKE, JC ;
VOELLER, DM ;
ALLEGRA, CJ ;
JOHNSTON, PG .
BRITISH JOURNAL OF CANCER, 1995, 71 (06) :1145-1150
[8]   A RANDOMIZED TRIAL OF FLUOROURACIL AND FOLINIC ACID IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA [J].
ERLICHMAN, C ;
FINE, S ;
WONG, A ;
ELHAKIM, T .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :469-475
[9]  
HOUGHTON JA, 1990, CANCER RES, V50, P3493
[10]   FACTORS THAT INFLUENCE THE THERAPEUTIC ACTIVITY OF 5-FLUOROURACIL [6RS]LEUCOVORIN COMBINATIONS IN COLON ADENOCARCINOMA XENOGRAFTS [J].
HOUGHTON, JA ;
WILLIAMS, LG ;
LOFTIN, SK ;
CHESHIRE, PJ ;
MORTON, CL ;
HOUGHTON, PJ ;
DAYAN, A ;
JOLIVET, J .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (06) :423-432